Skip to content

PP&E (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$7.79B+5.7%
Incyte logo
IncyteINCY
$709.47M-11.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$112.79M-16.6%
Precigen logo
PrecigenPGEN
$13.22M-9.9%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.28M-26.5%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$131.39M+17.8%

Segments

By geography

See full
U.S.$4.79B

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$166.77B+15.4%
Enterprise value$181.31B+10.3%
P/E18.1×-4.8×
P/S5.6×+0.6×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's PP&E (net)?
Gilead Sciences (GILD) reported PP&E (net) of $5.64B in Q1 2026.
How has Gilead Sciences's PP&E (net) changed year-over-year?
Gilead Sciences's PP&E (net) increased by 4.0% year-over-year, from $5.42B to $5.64B.
What is the long-term trend for Gilead Sciences's PP&E (net)?
Over 5 years (2020 to 2025), Gilead Sciences's PP&E (net) has grown at a 2.4% compound annual growth rate (CAGR), from $4.97B to $5.61B.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.